Orthopedics Inflammatory Process

Download Report

Transcript Orthopedics Inflammatory Process

Orthopedics Inflammatory Process
Jan Bazner-Chandler
RN, MSN, CNS, CPNP
Inflammatory Process

Osteomyelitis

Septic arthritis

Juvenile arthritis
Osteomyelitis
Webmd.lycos.com
Osteomyelitis

Infection of bone and tissue around bone.

Requires immediate treatment

Can cause massive bone destruction and life-threatening
sepsis
Pathogenesis of Acute Osteo
Under 1 year
the epiphysis is
nourished by
arteries.
In children 1 year
to 15 years the
infection is restricted
to below the
epiphysis.
Clinical Manifestation



Localized pain
Decreased movement of area
With spread of infection



Redness
Swelling
Warm to touch
Diagnostic Tests:





X-ray
CBC
ESR / erythrocyte sedimentation rate
C-reactive protein
Bone scan – most definitive test for osteomyelitis
X-Ray
18-year-old boy with painful right arm
Osteomyelitis
Management





Culture of the blood
Aspiration at site of infection
Intravenous antibiotics x 4 weeks
PO antibiotics if ESR rate going down
Monitor ESR

Decrease in levels indicates improvement
Goals of Care

To maintain integrity of infected joint / joints
Septic Arthritis


Infection within a joint or synovial membrane
Infection transmitted by:



Bloodstream
Penetrating wound
Foreign body in joint
Septic Arthritis of Hip


Difficulty walking and fever
Diagnosis: x-ray, ESR, aspiration of fluid from joint
Septic Hip
Flexed hip on affected
side is common presentation.
Diagnostic Tests
X-ray
Needle aspiration
under fluoroscopy
Erythrocyte Sedimentation Rate






ESR
Used as a gauge for determining the progress of an
inflammatory disease.
Rises within 24 hours after onset of symptoms.
Men:
0 - 15 mm./hr
Women: 0 – 20 mm./hr
Children: 0 – 10 mm./hr
C-Reactive Protein

During the course of an inflammatory process an
abnormal specific protein, CRP, appears in the blood.

The presence of the protein can be detected within 6
hours of triggering stimulus.

More sensitive than ESR / more expensive
Joint Space Fluid
WBC
80,000
Segs
88%
Monos
1%
Lymphs
11%
RBC
16,000
Gram Stain
Gram-positive cocci in
chains
Management




Administration of antibiotics for 4 to 6 weeks.
Oral antibiotics have been found to be effective if serum
bactericidal levels are adequate.
Fever control
Ibuprofen for anti-inflammatory effect
Juvenile Rheumatoid Arthritis

Chronic inflammatory condition of the joints and
surrounding tissues.

Often triggered by a viral illness

1 in 1000 children will develop JRA

Higher incidence in girls
Clinical Manifestations





Swelling or effusion of one or more joints
Limited ROM
Warmth
Tenderness
Pain with movement
Diagnostic Evaluation






Elevated ESR / erythrocyte sedimentation rate
+ genetic marker / HLA b27
+ RF 9 antinuclear antibodies
Bone scan
MRI
Arthroscopic exam
Goals of Therapy

To prevent deformities

To keep discomfort to a minimum

To preserve ability to do ADL
Management

First line drugs:




ASA
NSAIDs
Immunosuppressive drugs (oral): azulvadine or
methotrexate
Disease modifying drugs


Enbrel - IM
Remicade - IV
ASA Therapy

Alert: The use of aspirin has been highly associated
with the development of Reye’s syndrome in children
who have had chickenpox or flu. Because aspirin may
be an an ongoing p art of the regimen of the arthritic
child, parents should be warned of the relationship
between viral illnesses an aspirin, and be taught the
symptoms of Reye’s syndrome.
Management





Physical therapy
Exercise program
Monitor ESR levels
Regular eye exams: Iriditis
Cardiac involvement: early studies show some correlation
due to inflammatory process
Iriditis

Intraocular inflammation of iris and ciliary body

2% to 21% in children with arthritis

Highest incidence in children with multi joint involvement
disease.
Clinical Manifestations





Deep eye pain
Photophobia
Often report decrease in color perception
Redness no drainage
Treatment: prednisone eye drops or PO prednisone
Muscular Dystrophy

A group of more than 30 genetic diseases characterized
by progressive weakness and degeneration of the skeletal
muscles that control movement.
Duchenne




Most common form of MD and primarily affects boys.
Caused by absence of dystophin a protein needed to
maintain integrity of muscle.
Onset between 3 and 5 years
Rapid progression: unable to walk by age 12.
Treatment






No cure
Physical therapy
Respiratory therapy
Speech therapy
Orthopedic appliances / corrective procedures
Meds: corticosteroids and immununosuppressants to
slow progression of the disease.